Xenova Limited
Records under this name other than patents Xenova Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,218,393 | Anthranilic acid derivatives as multi drug resistance modulators Term ended Term ended Jun 9, 2019 · USPTO record | Term ended | Term ended Jun 9, 2019 | USPTO record |
| US 6,054,127 | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same Term ended Term ended Jun 27, 2017 · USPTO record | Term ended | Term ended Jun 27, 2017 | USPTO record |
| US 7,524,861 | Process for the preparation of a hydrate of an anthranilic acid derivative Lapsed on the fee record Ended Apr 28, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 28, 2017 | USPTO record |
| US 6,552,021 | Pharmaceutical compounds Lapsed on the fee record Ended Apr 22, 2015 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2015 | USPTO record |
| US 6,114,332 | Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents Lapsed on the fee record Ended Sep 5, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 5, 2012 | USPTO record |
| US 6,784,203 | Cytokine Production Inhibitors Formerly held Lapsed on the fee record Ended Aug 31, 2012 · High confidence | Lapsed on the fee record | Ended Aug 31, 2012 | High confidence |
| US 6,057,315 | Antibacterial agents Formerly held Lapsed on the fee record Ended May 2, 2012 · USPTO record | Lapsed on the fee record | Ended May 2, 2012 | USPTO record |
| US 7,132,419 | Pharmaceutical compounds Lapsed on the fee record Ended Nov 7, 2010 · USPTO record | Lapsed on the fee record | Ended Nov 7, 2010 | USPTO record |
| US 6,518,316 | Cytokine production and tyrosine kinase inhibitors Lapsed on the fee record Ended Feb 11, 2007 · USPTO record | Lapsed on the fee record | Ended Feb 11, 2007 | USPTO record |
| US 6,111,109 | Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide Lapsed on the fee record Ended Aug 29, 2004 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2004 | USPTO record |